Navigation Links
1 in 7 students has dabbled in 'smart' drugs
Date:11/14/2013

This news release is available in German.

American and European studies prove that students use prescription medication or drugs to enhance their cognitive performance. Researchers from the universities of Zurich and Basel examined whether Swiss students have also experimented with neuroenhancement and which substances they take by conducting a survey of 6,725 students with an average age of 23 at the two universities and ETH Zurich.

Majority consumes soft enhancers

Around 94 percent of the students surveyed had already heard of neuroenhancement. 13.8 percent of these students had tried to improve their cognitive performance with prescription medication or legal or illegal drugs at least once during their degrees. The substance most used was alcohol (5.6%), followed by methylphenidate such as Ritalin (4.1%), sedatives and soporifics (2.7%), cannabis (2.5%), beta-blockers (1.2%), amphetamines (0.4%), and cocaine (0.2%).

The respondents primarily took these substances during the exam preparation period, only consuming stimulating substances rarely in the exam situation or for general stress during their degrees. While daily neuroenhancement was a rare occurrence (1.8%), the majority consumed "soft enhancers" such as caffeinated products, non-prescription vitamin products or herbal sedatives before their last big exam around a third even every day.

The number of Swiss students who take neuroenhancing drugs is comparable with recent studies conducted at European universities. "The purported frequency of neuroenhancement at Swiss universities needs to be put into perspective as we asked about psychoactive and calmative substances," says PD Michael Schaub, the study leader and head of the Swiss Research Institute for Public Health and Addiction.

Narrow majority obtained desired effect

As a rule, advanced students who also had a job alongside their degrees and reported higher stress levels consumed performance-enhancing substances more frequently. Certain differences were apparent depending on the degree course: In Switzerland, students of the subjects architecture (19.6%), journalism (18.2%), chemistry (17.6%), economics (17.1%), medicine (16.2%), or pharmaceutics (16.1%) had more experience of neuroenhancement than budding mathematicians (8.6%) or sports students (7%), for instance.

According to the survey, the intended effect was only achieved in a narrow majority of the students, which is why only around half would actually take these substances to boost their brain power again. "The development of neuroenhancement at Swiss universities should be monitored as students constitute a high-risk group that is exposed to increased stress and performance pressure during their degrees," concludes Schaub. "However, there is no need to intervene as yet."


'/>"/>

Contact: Dr. Michael Schaub
michael.schaub@isgf.uzh.ch
41-444-481-165
University of Zurich
Source:Eurekalert  

Related medicine news :

1. UMA Staff and Students Make 'Strides' to Fight Breast Cancer
2. Feinstein Institute Encourages Science Education for NY Area Middle and High School Students
3. EECPL Develops New Series of Management Games for MBA students
4. Smart Kids with Learning Disabilities Announces the 2014 Fred J. Epstein Youth Achievement Award Contest, Celebrating the Outstanding Accomplishments of Students with LD
5. Dissertation Mania will Provide Sample Research Papers to Master’s Students
6. The Therapist Development Center Now Awarding MSW Scholarships for Second Year MSW Students with the “Promising Futures in Clinical Social Work” Scholarship Program
7. After a concussion, students may need gradual transition back to academics
8. Starting from scratch: RIT program teaches first-year students how to learn
9. Colorado State University-Global Campus Launches New Initiative for Military Students: Operation EDU
10. Classroom Diaries becomes one-stop information provider and advisor for students
11. 20 Nursing Students Awarded 2013 APNA Board of Directors Student Scholarships by the American Psychiatric Nurses Association
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
1 in 7 students has dabbled in 'smart' drugs
(Date:4/22/2017)... ... April 22, 2017 , ... ... as Vice President of Sales and Business Development at OAKWORKS, Inc. Mr. ... engagements, business development, and strategic planning for the company. Recognized industry-wide as ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... An April ... of a pair of ancient teeth, which reveal a great deal about prehistoric ice-age ... a sharp stone may have been used to remove decayed dental matter, and that ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to ... in the 2017 London Marathon. Set to take place on April 23rd, the London Marathon ... Dr. Schwartz will run as part of team EMPOWER, raising money for the international charity, ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Chicago plastic surgeon, ... removal of osteoma. An osteoma is a benign bony lump located on the forehead ... and can cause difficulties with sight and pain. Dr. Shah has discovered an approach ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: